| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2877115 | The Annals of Thoracic Surgery | 2011 | 7 Pages |
Abstract
Our data suggest that B7-H1 may represent a new prognostic marker for patients with Barrett carcinoma. Furthermore, given its immune-inhibitory function, B7-H1 may represent a potential target in the treatment of Barrett carcinoma.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Martin MD, Rupert MD, Tibor PhD, Ralf MD, Axel MD, Sandra PhD, Helmut MD, Marcus MD,